9F1 logo

Diagonal Bio DB:9F1 Stock Report

Last Price

€0.0025

Market Cap

€1.1m

7D

0%

1Y

-89.1%

Updated

16 Jun, 2024

Data

Company Financials

Diagonal Bio AB (publ) Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Diagonal Bio
Historical stock prices
Current Share Pricekr0.0025
52 Week Highkr0.063
52 Week Lowkr0.0023
Beta0.50
1 Month Change-3.85%
3 Month Change-67.11%
1 Year Change-89.13%
3 Year Changen/a
5 Year Changen/a
Change since IPO-99.77%

Recent News & Updates

Recent updates

Shareholder Returns

9F1DE BiotechsDE Market
7D0%-2.7%-3.1%
1Y-89.1%-24.2%-0.5%

Return vs Industry: 9F1 underperformed the German Biotechs industry which returned -24.2% over the past year.

Return vs Market: 9F1 underperformed the German Market which returned -0.5% over the past year.

Price Volatility

Is 9F1's price volatile compared to industry and market?
9F1 volatility
9F1 Average Weekly Movement29.6%
Biotechs Industry Average Movement4.2%
Market Average Movement5.0%
10% most volatile stocks in DE Market10.3%
10% least volatile stocks in DE Market2.5%

Stable Share Price: 9F1's share price has been volatile over the past 3 months.

Volatility Over Time: 9F1's weekly volatility (30%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
20204Karin Wehlindiagonalbio.com

Diagonal Bio AB (publ) operates as a biotechnology company in Sweden. The company offers LAMPlify, a customized system for general laboratory use to identify the presence of specific genetic markers for, for example, fungi, viruses, or bacteria. It is also involved in the development of PANVIRAL, a universal in vitro diagnostic system, that offers the potential for rapid and accurate point-of-care diagnoses in various settings, such as doctor’s office, surgery, mobile clinics, hospital bedsides, and workplaces and airports.

Diagonal Bio AB (publ) Fundamentals Summary

How do Diagonal Bio's earnings and revenue compare to its market cap?
9F1 fundamental statistics
Market cap€1.14m
Earnings (TTM)-€975.19k
Revenue (TTM)€210.68k

5.4x

P/S Ratio

-1.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
9F1 income statement (TTM)
Revenuekr2.37m
Cost of Revenuekr18.00k
Gross Profitkr2.35m
Other Expenseskr13.33m
Earnings-kr10.97m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 22, 2024

Earnings per share (EPS)-0.027
Gross Margin99.24%
Net Profit Margin-462.88%
Debt/Equity Ratio0%

How did 9F1 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.